Esperion Therapeutics

ESPR

NASDAQHealth Care

Income Statement

Total Revenue$332.31M

Gross Profit$263.71M

Operating Income$54.4M

EBITDA$7.57M

EBIT$7.51M

Pre-tax Income$-5.58M

Net Income$-51.75M

Cash Equivalent$176.35M

Total Debt$564.08M

Book Value$-349.36M

Book Value Per Share-1.82

Return on Equity (ROE)-486.00%

Return on Assets (ROA)-15.05%

Return on Invested Capital (ROI)-486.00%

Net Profit Margin-15.57%

Current Ratio1.37

Quick Ratio0.91

Long-Term Debt / Equity0.00